Capital Research Global Investors’s Oak Street Health, Inc. OSH Stock Holding History

Capital Research Global Investors’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,269,001	Closed	-$87.8M	–	444
2023 Q1	$87.8M	Sell	2,269,001 -14,053,946	-86%	-$454M	0.03%	285
2022 Q4	$351M	Sell	16,322,947 -1,455,922	-8%	-$30.5M	0.11%	162
2022 Q3	$436M	Buy	17,778,869 +3,905,081	+28%	+$103M	0.14%	142
2022 Q2	$228M	Buy	13,873,788 +2,021,708	+17%	+$39.3M	0.07%	202
2022 Q1	$319M	Buy	11,852,080 +4,491,941	+61%	+$94.7M	0.08%	196
2021 Q4	$244M	Buy	7,360,139 +4,072,919	+124%	+$154M	0.05%	228
2021 Q3	$140M	Buy	+3,287,220	New	+$177M	0.03%	280

Other funds holding OSH

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capital Research Global Investors's OSH Position: Q2 2023 in Review

Capital Research Global Investors sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 2,269,001 shares — an estimated $87.8M sold.

Capital Research Global Investors first reported a position in OSH in Q3 2021 and held it in 7 quarters. The position peaked at $436M in Q3 2022. 2 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Capital Research Global Investors reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Capital Research Global Investors sold 2,269,001 Oak Street Health, Inc. shares in Q2 2023, an estimated $87.8M.
Capital Research Global Investors first reported a position in Oak Street Health, Inc. in Q3 2021 and held it in 7 quarters.
Capital Research Global Investors's Oak Street Health, Inc. position peaked at $436M in Q3 2022.
2 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Capital Research Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.